These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7266416)

  • 1. [Effective prevention of thromboembolism with heparin and dihydroergotamine].
    Adolf J; Buttermann G; Theisinger W
    Med Klin; 1981 Jul; 76(16):457-8. PubMed ID: 7266416
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prevention of thromboembolism with heparin and dihydroergotamine (DHE) in internal medicine--comparison of various administration forms of dihydroergotamine].
    Schott G; Kreibich U; Sommer S; Möckel G; Beitz R; Rothe G
    Z Arztl Fortbild (Jena); 1988; 82(11):509-11. PubMed ID: 3051706
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use of heparin in combination with dihydroergotamine for the postoperative prevention of thrombosis in general surgery].
    Schott G
    Z Gesamte Inn Med; 1984 Sep; 39(17):431-5. PubMed ID: 6506818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapeutic advances in thromboembolic disease. I. Dihydroergotamine + heparin].
    de Diego I; Jané F; Félez J
    Sangre (Barc); 1981; 26(4):471-83. PubMed ID: 7027494
    [No Abstract]   [Full Text] [Related]  

  • 5. [Ergotism within the scope of the postoperative prevention of thromboembolism].
    Kneist W; Heesen U; Assmann H
    Zentralbl Chir; 1987; 112(22):1426-35. PubMed ID: 3439378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylaxis of postoperative thromboembolism: low dose heparin versus heparin plus dihydroergotamine.
    Brücke P; Dienstl E; Vinazzer H; Simma W
    Thromb Res; 1983 Feb; 29(3):377-82. PubMed ID: 6845285
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacokinetics of heparin in healthy and obese subjects and in combination with dihydroergotamine.
    Beermann B; Lahnborg G
    Thromb Haemost; 1981 Feb; 45(1):24-6. PubMed ID: 7245123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Problems and prospects for clinical heparin use].
    Verstraete M
    Kardiologiia; 1981 Aug; 21(8):28-31. PubMed ID: 7026867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Sandoparin dihydroergotamine. A combination preparation for prevention of thrombosis].
    Wille-Jørgensen PA
    Ugeskr Laeger; 1991 Aug; 153(34):2370-2. PubMed ID: 1897057
    [No Abstract]   [Full Text] [Related]  

  • 10. [Combination of low molecular weight heparin and dihydroergotamine for prevention of thrombosis].
    Haas S
    Dtsch Med Wochenschr; 1995 Apr; 120(14):503. PubMed ID: 7712947
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of low-dose heparin and dihydroergotamine on frequency of postoperative deep-vein thrombosis in patients undergoing post-traumatic hip surgery.
    Lahnborg G
    Acta Chir Scand; 1980; 146(5):319-22. PubMed ID: 7468062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin with and without dihydroergotamine in prevention of thromboembolic complications of major abdominal surgery. A randomized trial.
    Wille-Jørgensen P; Kjaergaard J; Thorup J; Jørgensen T; Fogh J; Munck O; Andersen B
    Arch Surg; 1983 Aug; 118(8):926-8. PubMed ID: 6347123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Complications in drug prevention of thromboembolism].
    Tittel K
    Unfallchirurgie; 1985 Jun; 11(3):150-5. PubMed ID: 4035815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevention of thrombo-embolic disease: current approach (author's transl)].
    Kakkar VV
    J Mal Vasc; 1981; 6(4):245-50. PubMed ID: 7320640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevention of thromboembolism using drugs in operative medicine].
    Rasche H
    Dtsch Med Wochenschr; 1983 Dec; 108(51-52):l983-4. PubMed ID: 6653430
    [No Abstract]   [Full Text] [Related]  

  • 16. [Acute ischemia due to vasospasm following prevention of thrombosis with dihydroergotamine/heparin].
    Meybier H; Krämer KL; Maeder N; Kretzschmar U; Allenberg JR
    Rontgenpraxis; 1987 Aug; 40(8):287-94. PubMed ID: 3660102
    [No Abstract]   [Full Text] [Related]  

  • 17. Risk/benefit of heparin-dihydroergotamine thromboembolic prophylaxis.
    Schlag G; Poigenfürst J; Gaudernak T
    Lancet; 1986 Dec 20-27; 2(8521-22):1465. PubMed ID: 2878318
    [No Abstract]   [Full Text] [Related]  

  • 18. [Thromboembolism prophylaxis with reduced bleeding risk. Trials with heparin-dihydroergot 2500].
    Koppenhagen K; Häring R
    Med Welt; 1981 Jun; 32(25):1021-2. PubMed ID: 7278579
    [No Abstract]   [Full Text] [Related]  

  • 19. [Circulatory insufficiency during prevention of thrombosis with heparin/dihydroergotamine. Effect or side-effect?].
    Borris LC; Lassen MR; Christiansen HM; Møller-Larsen F; Knudsen VE; Nielsen BW
    Ugeskr Laeger; 1988 Jul; 150(27):1682-3. PubMed ID: 3388590
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of enoxaparin in prevention of deep venous thrombosis in hip and knee surgery--a comparison with the dihydroergotamine-heparin combination.
    Perhoniemi V; Vuorinen J; Myllynen P; Kivioja A; Lindevall K
    Ann Chir Gynaecol; 1996; 85(4):359-63. PubMed ID: 9014067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.